ly 293558 has been researched along with ym 872 in 1 studies
| Studies (ly 293558) | Trials (ly 293558) | Recent Studies (post-2010) (ly 293558) | Studies (ym 872) | Trials (ym 872) | Recent Studies (post-2010) (ym 872) |
|---|---|---|---|---|---|
| 103 | 4 | 18 | 41 | 0 | 5 |
| Protein | Taxonomy | ly 293558 (IC50) | ym 872 (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 6 | Homo sapiens (human) | 3 | |
| Solute carrier family 22 member 8 | Homo sapiens (human) | 6.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carcache, D; Kalkman, HO; Koller, M; Mattes, H | 1 |
1 other study(ies) available for ly 293558 and ym 872
| Article | Year |
|---|---|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA | 2010 |